Microbiologically documented infections in patients undergoing high-dose melphalan and autologous stem cell transplantation for the treatment of light chain amyloidosis.

Taimur, S

Microbiologically documented infections in patients undergoing high-dose melphalan and autologous stem cell transplantation for the treatment of light chain amyloidosis. [electronic resource] - Transplant infectious disease : an official journal of the Transplantation Society Apr 2013 - 187-94 p. digital

Publication Type: Journal Article

1399-3062

10.1111/tid.12037 doi


Aged
Aged, 80 and over
Amyloidosis--therapy
Bacterial Infections--diagnosis
Combined Modality Therapy
Cross Infection--etiology
Dose-Response Relationship, Drug
Female
Humans
Immunoglobulin Light Chains
Male
Melphalan--administration & dosage
Middle Aged
Mycoses--diagnosis
Myeloablative Agonists--administration & dosage
Postoperative Complications
Risk Factors
Stem Cell Transplantation--adverse effects
Transplantation, Autologous